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Background: Sepsis is one of the most common causes of morbidity and mortality in the newborn. Early diagnosis
and treatment is vital to improve outcome. The present study was therefore carried out to determine the usefulness
of C-reactive protein (CRP) for evaluation of neonatal sepsis in Port Harcourt, Nigeria in Sub-Saharan Africa.
Method: Four hundred and twenty neonates with clinical suspicion of sepsis were prospectively studied over a
6 month period. Blood was obtained from each subject recruited for the qualitative estimation of CRP. Blood culture
was used as gold standard for diagnosis of NNS.
Results: Of 420 neonates studied, 196 (46.7%) had positive CRP while 181 (43.1%) had positive blood culture. The
sensitivity, specificity, positive and negative predictive values of CRP were 74.0%, 74.1%, 68.4% and 79.0%
respectively.
Conclusion: The qualitative method of estimating CRP which is cheap and rapid has moderate sensitivity, specificity
and negative predictive value.
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Neonatal sepsis (NNS) and neonatal septicaemia are
terms that have been used to describe the systemic re-
sponse to infection and/or isolation of bacteria from the
blood stream in the first 28 days of life [1]. Globally, sep-
sis accounts for 26% of all neonatal deaths [2] with 98%
of these deaths occurring in developing countries [3].
Adequate and timely diagnosis of NNS remains an im-
portant challenge to the clinician. Blood culture is the
gold standard for definitive diagnosis but it takes at least
48 hours by which time the infection may have pro-
gressed with important consequences on the morbidity
and mortality of the neonate [4], especially if antibiotic
treatment is not initiated immediately [5]. Initiation of
antibiotic therapy before diagnostic results are available
is recommended for neonates with clinical signs or risk
factors of sepsis [6], but because the clinical signs of* Correspondence: Email: docolyemen@yahoo.com
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reproduction in any medium, provided the orNNS are often non-specific, empiric antibiotic therapy
may result in the treatment of as many as 30 uninfected
neonates for every one who is eventually diagnosed to
be infected [7-9]. Hence there is need for rapid screen-
ing test that can identify infected neonates at the time of
initial assessment thus sparing the uninfected ones from
unnecessary antibiotic therapy.
C-reactive protein is an acute phase protein which may
be useful in the early diagnosis of NNS as it rises as
much as a thousand fold within 4 to 6 hours of an in-
flammatory process [10,11]. As infection is the most
likely cause of inflammation in the neonate, CRP has
been shown to be useful in the diagnosis of neonatal sep-
sis. Upon resolution of the inflammation, CRP levels rap-
idly decline with an elimination half life of 19 hours
[11,12]. Thus CRP level is also a useful marker in deter-
mining the duration of antibiotic therapy. Unlike blood
culture, CRP level is not affected by prior antibiotic ther-
apy [13], so may be particularly useful in Sub-Saharan
Africa where a significant number of neonates may have
been given antibiotics before presentation at the hospital.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
West et al. Antimicrobial Resistance and Infection Control 2012, 1:22 Page 2 of 5
http://www.aricjournal.com/content/1/1/22CRP can be assayed quantitatively or qualitatively. The
quantitative method is more widely used in developed
countries [12]. It provides rapid, highly sensitive and
specific results [14] but requires more time (about 15 to
30 minutes) and is more complex and expensive to per-
form [12]. The test kits may also not be readily available
in some health centres in developing countries. The
qualitative method provides rapid results within 15 min-
utes. However, it is less specific but has the advantage of
being simple and easier to perform and interpret and as
such can be performed at the patients bed side or side
laboratory [14,15]. It is also less expensive and requires
less skill. The qualitative method may therefore, be more
feasible in resource poor centres, where poverty plays a
prominent role in disease morbidity and mortality and
where there may be no laboratory services or trained
man-power for the investigation of neonates with sus-
pected sepsis which is indeed the case in many areas of
Sub-Saharan Africa.
To the knowledge of the authors, no study was found
on the use of C-reactive protein in the detection of NNS
in Nigeria. This study was therefore undertaken to ascer-
tain the usefulness of C-reactive protein in the diagnosis
and management of NNS.
Materials and methods
Approval was obtained from the ethics and research
committee of the University of Port Harcourt Teaching
Hospital and informed consent was obtained from the
parent or care givers of the neonates.
A prospective study was carried out in the Special
Care Baby Unit (SCBU) of the University of Port Har-
court Teaching Hospital, Rivers State, Nigeria, within a
6 month period from May to November, 2007. All new-
borns with clinical suspicion or risk factors for sepsis
were consecutively recruited into the study. Sepsis was
suspected in the presence of clinical features like fever,
respiratory distress, poor feeding, jaundice, hypothermia,
convulsion, vomiting, irritability, lethargy and abdominal
distension. Risk factors for sepsis included outborn de-
livery, perinatal asphyxia, preterm delivery, prolonged
rupture of membranes, maternal peripartum pyrexia and
foul smelling amniotic fluid.
Infants of mothers who had intrapartum antibiotics
within 1 week of delivery as well as babies with prior
antibiotic therapy for present illness before admission
into the SCBU were excluded from the study.
C-reactive protein was estimated qualitatively using
the Lorne CRP latex kit manufactured by the Lorne
laboratories Limited (Great Britain) with catalogue
number, 041100. The specific performance characteris-
tics of the Lorne CRP latex reagent was standardized
to detect serum CRP levels at or above 6 mg/l, which
is considered the lowest concentration of clinicalsignificance. Half a milliliter of venous blood was col-
lected in plain bottles and centrifuged. C-reactive protein
was estimated using a drop of undiluted serum placed
onto the circle of the agglutination slide with the use of
disposable pipettes provided in the kit. One drop of CRP
latex reagent was added to the drop of serum and the
broad end of the pipette was used to spread the latex re-
agent over the entire area of the test circle. The agglutin-
ation slide was gently tilted backwards and forwards
approximately once every two seconds for two minutes.
The results were read using the positive and negative
controls as reference for agglutination. Visible agglutin-
ation of latex particles constituted a positive result which
indicated a level of CRP> 6 mg/l while negative result
was the reverse. After the results were read, the glass
slide was rinsed with distilled water and air dried prop-
erly for re-use.
Blood culture was done for all recruited babies using
two milliliter of venous blood collected from a periph-
eral vein after adequate skin preparation and before the
commencement of antibiotics. The blood was aseptically
introduced into aerobic and anaerobic culture media.
The specimens were processed according to standard
methods in the microbiology laboratory [16]. Inoculated
blood culture media were considered negative if there
was no growth after continuous incubation for up to
7 days, subcultures being made each day. Antibiotic sen-
sitivity was done using Kirby-Bauer disc diffusion
method [16].
The results of laboratory investigations and other rele-
vant data such as age, sex, birth weight and gestational
age as well as symptoms present and risk factors for sep-
sis of recruited babies were recorded in a proforma. The
results were analysed using the statistical package, SPSS
version 14.0. The sensitivity, specificity, positive and
negative predictive values of CRP were calculated.Results
Of the 545 neonates admitted into the SCBU during the
period of study, 420 (77.1%) were studied. There were
273 (65.0%) males and 147 (35.0%) females with mean
gestational age (±SD) of 36.8 weeks (± 3.6) and mean
birth weight (±SD) of 2.8 kg (±0.9). Three hundred and
two (71.9%) of the study population had clinical features
of sepsis, while 271 (64.5%) had risk factors for sepsis.
Of 420 neonates screened for sepsis, 181 (43.1%) had
positive blood culture.Prevalence of positive C-reactive protein in neonates with
suspected sepsis
Of the 420 neonates with suspected sepsis, 196 (46.7%)
had positive CRP while 224 (53.3%) had negative CRP.
Table 1 Sensitivity, Specificity, Positive and Negative
Predictive Values of C-reactive protein using blood
culture as gold standard





Positive predictive value 134 68.4
134 + 62
Negative predictive value 177 79.0
177 + 47













No % No % No %
Outborn Delivery 160 59.0 59 36.9 47 79.8
Perinatal Asphyxia 127 46.9 55 43.3 39 70.9
Prolonged Rupture
of membranes
100 36.9 32 32.0 24 75.0
Prematurity 85 31.4 38 44.7 28 73.7
Foul smelling
amniotic fluid
48 17.7 12 25.0 10 83.3
Peripartum pyrexia 22 8.1 11 50.0 9 81.8
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C-reactive protein using blood culture as gold standard
Of the 420 neonates studied, 181 (43.1%) had positive
blood culture while 239 (56.9%) had negative blood cul-
ture. Of the 181 neonates with positive blood culture,
134 (74.0%) had positive CRP (True positive) while 47
(26.0%) had negative CRP (False negative). Of 239 neo-
nates with negative blood culture, 177 (74.1%) had nega-
tive CRP (True negative) and 62 (25.9%) had positive
CRP (False positive)
Sensitivity, specificity, positive and negative predictive
values of C-reactive protein
As shown in Table 1, the sensitivity, specificity, positive
and negative predictive values were 74.0%, 74.1%, 68.4%
and 79.0%, respectively.
Performance of CRP according to clinical features of
sepsis
Table 2 shows the clinical features suggestive of sepsis.










No % No % No %
Fever 116 38.4 52 44.8 42 80.8
Respiratory distress 112 37.1 48 42.9 37 77.1
Jaundice 81 26.8 27 33.3 22 81.5
Poor suck 75 24.8 39 52.0 29 74.4
Apnoea 27 8.9 7 25.9 7 100.0
Hypothermia 26 8.6 14 53.8 8 57.1
Convulsion 20 6.6 10 50.0 6 60.0
Vomiting 15 5.0 9 60.0 9 100.0
Irritability 10 3.3 6 60.0 5 83.3
Lethargy 10 3.3 6 60.0 6 100.0most common was fever in 116 (38.4%) of them, fol-
lowed by respiratory distress in 112 (37.1%). The CRP
correctly identified all (100%) of the neonates with posi-
tive blood culture who presented with apnoea, vomiting
and lethargy.
Performance of CRP according to predisposing factors for
sepsis
As shown in Table 3, of the 271 neonates with predis-
posing factors for sepsis, the most common was out
born delivery in 160 (59.0%) of them followed by peri-
natal asphyxia in 127 (46.9%). The CRP was able to cor-
rectly identify 83.3% and 81.8% of the neonates with
positive blood culture who were born to mothers with
foul smelling amniotic fluid and peri-partum pyrexia
respectively.
Performance of CRP in the neonates with proven sepsis
As shown in Table 4, of the 181 neonates with positive
blood culture, the most common organism isolated was







No % No %
Klebsiella pneumonia 105 58.0 100 95.2
Staphylococcus aureus 37 20.4 35 94.6
Escherichia coli 14 7.7 14 100.0
Proteus spp 9 5.0 9 100.0
Pseudomonas aerugenosa 8 4.4 5 62.5
Enterococcus spp 3 1.7 3 100.0
Staphylococcus epidermidis 3 1.7 3 100.0
Streptococcus spp 2 1.1 2 100.0
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to correctly identify all cases (100.0%) of neonatal sepsis
caused by Escherichia coli, Proteus spp, Enterococcus
spp, Staphylococcus epidermidis and Streptococcus spp.
Discussion
The prevalence of blood culture proven sepsis in the
present study was 43.1%. This is similar to the 41.7%
reported by Chako and Sohi [17], 42% by Mustafa et al.
[15] and 47.5% by Roy et al. [18]. It is however higher
than the 36.4% reported by Antia-Obong and Utsalo
[19], 28% by Zeeshan et al. [20], 14% by Manucha et al.
[21] and 10.7% by Ugochukwu [22].
The commonest organism isolated was klebsiella pneu-
monia followed by staphylococcus areus. From 1974 to
1978, Omene [3] in Benin city found Escherichia coli to
be the predominant bacterial isolate in neonatal sepsis.
Antia Obong and Utsalo [19] in Calabar reported Sta-
phylococcus aureus as the predominant bacterial isolate
from 1985 to 1987. Ugochukwu [23] also found Staphy-
lococcus aureus as the predominant bacterial isolate in
neonatal sepsis in Nnewi Nigeria, from 1998 to 2001.
This shows a changing pattern of bacterial isolates over
the years in the Southern region of Nigeria. Similar to
the finding in the present study, Roy et al. [18] in India
reported Klebsiella spp as the predominant bacterial iso-
late in neonatal sepsis.
Among the clinical features of neonatal sepsis in the
present study, CRP performance was highest in neonates
with apnoea, vomiting and lethargy and lowest in those
with hypothermia and convulsion. The lower levels in
neonates with hypothermia and convulsion may be due
to the fact that there are other commoner causes of neo-
natal hypothermia and convulsions other than sepsis.
Among the risk factors for neonatal sepsis, CRP per-
formance was highest in neonates born to mothers with






















*present study.pyrexia. This is similar to findings by Mathai et al. [23]
in Tamil, Nadu who reported a significant association
between maternal peri-partum pyrexia and neonatal
positive CRP levels. Unlike the present study however,
they found no significant association between foul smel-
ling amniotic fluid and positive CRP levels.
In the present study, CRP identified 134 out of 181
neonates who had culture-proven sepsis, with sensitiv-
ity of 74.0% and a negative predictive value of 79.0%,
implying that close to three quarters of neonates with
suspected sepsis will be correctly diagnosed using CRP.
This means that one out of every four neonates with
sepsis will be missed. This is much too high to base
the decision not to start empirical antibiotics for a neo-
nate with suspected sepsis. Particularly as CRP was
only tested to predict positive blood culture which may
represent only a proportion of neonates with sepsis
[24], especially if the patient had been on antibiotic
therapy before presentation as is common in Sub-
Saharan Africa. A negative CRP, however can be useful
in aiding the decision to discontinue antibiotics espe-
cially if the neonate has no clinical feature of sepsis.
Kashabi et al. [13] demonstrated that CRP can be a
useful guide in making a decision to discontinue anti-
biotic therapy, thus facilitating early discharge with sig-
nificantly reduced cost, complications of treatment and
family anxiety.
Several authors in different settings have reported dif-
ferent performances for usefulness of CRP in the diagno-
sis and management of neonatal sepsis. The main
differences and the CRP performances are as outlined in
Table 5. Nuntnarumit et al. [25] in Bangkok Thailand,
reported the highest sensitivity, specificity, positive pre-
dictive values and negative predictive value. This is prob-
ably due to the quantitative sampling method which
they used as compared to the qualitative method used in
the present study. Also as shown in Table 5, authorsPerformance
nsitivity specificity PPV NPV
0.0% 94.0% 91.6% 100.0%
8.6% 87.5% 91.7% 70.0%
0.0% 60.0% 7.7% 98.6%
5.6% 95.0% 82.7% 95.9%
6.0% 79.0% 37.0% 96.0%
4.0% 74.1% 68.4% 79.0%
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CRP reported higher performance values than those who
used the qualitative method.
Conclusion
The qualitative method of CRP estimation, which is a
rapid, inexpensive and simple test to perform, was found
to have moderate sensitivity, specificity and NPV of
74.0%, 74.1% and 79.0%, respectively. This implies that
CRP would correctly identify close to three quarters of
neonates with sepsis and would have 79.0% probability
in excluding sepsis.
The C-reactive protein may therefore, help in the early
detection of neonatal sepsis while awaiting blood culture
results. CRP may also be invaluable in the management
of neonatal sepsis in resource poor centres where facil-
ities for blood culture may not be readily available.
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